Jul 7, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- Aug 7, 2026
Congress ticker disclosure profile
As of August 13 at 1:12 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference BLDR. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
3
Feed lifetime
30
Member filers
3
Disclosed ranges
$96K
Most active member desks
17 buys vs 13 sells
Latest trade Jul 7, 2026
Jul 7, 2026
Ro KhannaJun 2, 2026
Ro KhannaMay 27, 2026
Ro KhannaMay 1, 2026
Ro KhannaApr 24, 2026
Ro KhannaMar 30, 2026
Ro KhannaFeb 24, 2026
Ro KhannaJan 22, 2026
Ro KhannaAug 13, 2025
Ro KhannaMay 28, 2025
Ro KhannaMay 19, 2025
Ro KhannaApr 23, 2025
Ro KhannaFeb 19, 2025
Ro KhannaAug 7, 2024
Ro KhannaAug 5, 2024
Ro KhannaAug 2, 2024
Ro KhannaJul 19, 2024
Ro KhannaNov 30, 2022
Susie LeeNov 2, 2022
Ro KhannaAug 3, 2022
Kathy ManningJul 20, 2022
Kathy ManningJun 27, 2022
Ro KhannaMay 23, 2022
Ro KhannaMay 10, 2022
Ro KhannaAug 17, 2021
Susie LeeMay 14, 2021
Susie LeeFeb 9, 2021
Susie LeeOct 22, 2020
Susie LeeJun 5, 2020
Susie LeeJun 3, 2020
Susie Lee| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jul 7, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Aug 7, 2026 | Open card |
| Jun 2, 2026 | Ro Khanna | Sell | $1,001 to $15,000 | Jul 6, 2026 | Open card |
| May 27, 2026 | Ro Khanna | Sell | $1,001 to $15,000 | Jun 9, 2026 | Open card |
| May 1, 2026 | Ro Khanna | Buy | $1,001 to $15,000 | Jun 9, 2026 | Open card |
| Apr 24, 2026 | Ro Khanna | Buy | Receipt pending ingestion | May 11, 2026 | Open card |
| Mar 30, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Apr 7, 2026 | Open card |
| Feb 24, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Jan 22, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Feb 6, 2026 | Open card |
| Aug 13, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Sep 9, 2025 | Open card |
| May 28, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Jun 10, 2025 | Open card |
| May 19, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Jun 10, 2025 | Open card |
| Apr 23, 2025 | Ro Khanna | Buy | Receipt pending ingestion | May 12, 2025 | Open card |
| Feb 19, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Mar 6, 2025 | Open card |
| Aug 7, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Sep 6, 2024 | Open card |
| Aug 5, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Sep 6, 2024 | Open card |
| Aug 2, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Sep 6, 2024 | Open card |
| Jul 19, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Aug 7, 2024 | Open card |
| Nov 30, 2022 | Susie Lee | Sell | $1,001 to $15,000 | Dec 29, 2022 | Open card |
| Nov 2, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Dec 6, 2022 | Open card |
| Aug 3, 2022 | Kathy Manning | Sell | $1,001 to $15,000 | Sep 14, 2022 | Open card |
| Jul 20, 2022 | Kathy Manning | Buy | $1,001 to $15,000 | Aug 10, 2022 | Open card |
| Jun 27, 2022 | Ro Khanna | Sell | Receipt pending ingestion | Jul 7, 2022 | Open card |
| May 23, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jun 10, 2022 | Open card |
| May 10, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jun 10, 2022 | Open card |
| Aug 17, 2021 | Susie Lee | Sell | $1,001 to $15,000 | Sep 10, 2021 | Open card |
| May 14, 2021 | Susie Lee | Buy | $1,001 to $15,000 | Jun 14, 2021 | Open card |
| Feb 9, 2021 | Susie Lee | Buy | $1,001 to $15,000 | Mar 11, 2021 | Open card |
| Oct 22, 2020 | Susie Lee | Sell | $1,001 to $15,000 | Dec 8, 2020 | Open card |
| Jun 5, 2020 | Susie Lee | Buy | $1,001 to $15,000 | Jul 10, 2020 | Open card |
| Jun 3, 2020 | Susie Lee | Buy | $1,001 to $15,000 | Jul 10, 2020 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 12 of 30 filed rows include disclosed amount ranges (40%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.